← Leaderboards

Lee W Riley

University Of California Berkeley

Google Scholar ↗PubMed ↗ORCID ↗

$13,436,523

Attributed

$26,714,409

Total exposure

16

Grants

10

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3M · FY2005–22

$5M$3.8M$2.5M$1.3M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

Funding mix

By agency

NIH$26,714,409 · 16

By mechanism

D43$9,716,290 · 4

R01$8,850,986 · 5

R25$5,233,588 · 1

R33$1,386,261 · 1

R21$825,675 · 2

R24$425,303 · 1

Top collaborators

Michele Barry39 shared
Albert Icksang Ko39 shared
Purnima Madhivanan39 shared
Niren Murthy11 shared
Luke P. Lee6 shared

Most similar at University Of California Berkeley

Same institution · by research overlap

Luke P. Lee$11,379,071

Others in their field

Top investigators on “Communicable Diseases”

Jeffrey P Krischer · University Of South Florida$580,775,398
Judith S. Currier · University Of California Los Angeles$277,419,428
Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$240,302,862
Melynda Holmes · Technical Resources Inc$231,847,503
Lawrence Corey · Fred Hutchinson Cancer Center$228,424,910
Glenda E Gray · Wits Health Consortium (Pty), Ltd$227,738,417

Research focus

Communicable DiseasesTrainingResearch PersonnelCaliforniaTraining ProgramsSiteResearch TrainingProgramsDesignUniversitiesInstitutionCommunitiesMentorsMentorshipInternationalGlobal HealthCountryCareerMultidisciplinaryDisciplinePostdoctoral FellowMemberEastern EuropeEnvironmental Health

Grant awards (85)

Global Health Equity Scholars Program.$198,936

D43 · FY2022 · TW

Global Health Equity Scholars Program.$103,326

D43 · FY2022 · TW

Global Health Equity Scholars Program.$66,312

D43 · FY2022 · TW

Global Health Equity Scholars Program.$66,312

D43 · FY2022 · TW

Global Health Equity Scholars Program.$51,663

D43 · FY2022 · TW

Global Health Equity Scholars Program - D43 Fogarty Training$4,333

D43 · FY2022 · TW · contact PI

Global Health Equity Scholars Program - D43 Fogarty Training$900,000

D43 · FY2021 · TW · contact PI

Research Training at the Confluence of Infectious and Non-Communicable Diseases in India$215,986

D43 · FY2021 · TW · contact PI

Global Health Equity Scholars Program - D43 Fogarty Training$116,573

D43 · FY2021 · TW · contact PI

Global Health Equity Scholars Program - D43 Fogarty Training$54,203

D43 · FY2021 · TW · contact PI

Global Health Equity Scholars Program - D43 Fogarty Training$823,188

D43 · FY2020 · TW · contact PI

Global Health Equity Scholars Program - D43 Fogarty Training$106,020

D43 · FY2020 · TW · contact PI

Global Health Equity Scholars Program - D43 Fogarty Training$53,757

D43 · FY2020 · TW · contact PI

Global Health Equity Scholars Program - D43 Fogarty Training$53,757

D43 · FY2020 · TW · contact PI

Global Health Equity Scholars Program - D43 Fogarty Training$18,000

D43 · FY2020 · TW · contact PI

Research Training at the Confluence of Infectious and Non-Communicable Diseases in India$1

D43 · FY2020 · TW · contact PI

Consortium for drug-resistant Gram-negative pathogen detection$1,071,131

R01 · FY2019 · AI · contact PI

Global Health Equity Scholars Program - D43 Fogarty Training$900,000

D43 · FY2019 · TW · contact PI

Maltose Targeted Antibiotics$462,087

R33 · FY2019 · AI

Research Training at the Confluence of Infectious and Non-Communicable Diseases in India$216,284

D43 · FY2019 · TW · contact PI

Global Health Equity Scholars Program - D43 Fogarty Training$109,566

D43 · FY2019 · TW · contact PI

Global Health Equity Scholars Program - D43 Fogarty Training$48,870

D43 · FY2019 · TW · contact PI

Global Health Equity Scholars Program - D43 Fogarty Training$47,250

D43 · FY2019 · TW · contact PI

Global Health Equity Scholars Program - D43 Fogarty Training$47,250

D43 · FY2019 · TW · contact PI

Global Health Equity Scholars Program - D43 Fogarty Training$8,000

D43 · FY2019 · TW · contact PI

Consortium for drug-resistant Gram-negative pathogen detection$1,106,988

R01 · FY2018 · AI · contact PI

Global Health Equity Scholars Program - D43 Fogarty Training$1,008,089

D43 · FY2018 · TW · contact PI

Maltose Targeted Antibiotics$462,087

R33 · FY2018 · AI

Global Health Equity Scholars Program - D43 Fogarty Training$122,584

D43 · FY2018 · TW · contact PI

Global Health Equity Scholars Program - D43 Fogarty Training$108,796

D43 · FY2018 · TW · contact PI

Global Health Equity Scholars Program - D43 Fogarty Training$47,250

D43 · FY2018 · TW · contact PI

Consortium for drug-resistant Gram-negative pathogen detection$1,185,876

R01 · FY2017 · AI · contact PI

Global Health Equity Scholars Program - D43 Fogarty Training$900,000

D43 · FY2017 · TW · contact PI

Maltose Targeted Antibiotics$462,087

R33 · FY2017 · AI

Global Health Equity Scholars Program - D43 Fogarty Training$243,176

D43 · FY2017 · TW · contact PI

Research Training at the Confluence of Infectious and Non-Communicable Diseases in India$216,829

D43 · FY2017 · TW · contact PI

Consortium for drug-resistant Gram-negative pathogen detection$1,118,080

R01 · FY2016 · AI · contact PI

Global Health Fellows and Scholars Research Training$820,000

R25 · FY2016 · TW · contact PI

Global Health Fellows and Scholars Research Training$212,427

R25 · FY2016 · TW · contact PI

Maltose Targeted Antibiotics$209,372

R21 · FY2016 · AI

Global Health Fellows and Scholars Research Training$91,716

R25 · FY2016 · TW · contact PI

Consortium for drug-resistant Gram-negative pathogen detection$59,660

R01 · FY2016 · AI · contact PI

Global Health Fellows and Scholars Research Training$7,633

R25 · FY2016 · TW · contact PI

Consortium for drug-resistant Gram-negative pathogen detection$1,154,056

R01 · FY2015 · AI · contact PI

Global Health Fellows and Scholars Research Training$910,000

R25 · FY2015 · TW · contact PI

Maltose Targeted Antibiotics$204,553

R21 · FY2015 · AI

Global Health Fellows and Scholars Research Training$41,040

R25 · FY2015 · TW · contact PI

Global Health Fellows and Scholars Research Training$911,000

R25 · FY2014 · TW · contact PI

Global Health Fellows and Scholars Research Training$32,400

R25 · FY2014 · TW · contact PI

Global Health Fellows and Scholars Research Training$22,680

R25 · FY2014 · TW · contact PI

Global Health Fellows and Scholars Research Training$5,000

R25 · FY2014 · TW · contact PI

Global Health Fellows and Scholars Research Training$1,043,372

R25 · FY2013 · TW · contact PI

Global Health Fellows and Scholars Research Training$31,320

R25 · FY2013 · TW · contact PI

Global Health Fellows and Scholars Research Training$1,105,000

R25 · FY2012 · TW · contact PI

Emerging drug-resistance infections$189,778

D43 · FY2012 · TW · contact PI

Emerging drug-resistance infections$189,778

D43 · FY2011 · TW · contact PI

Framework to Address Drug Resistant Infections and Global Health$425,303

R24 · FY2010 · TW · contact PI

In vivo regulation of M. tuberculosis cell wall lipids$377,686

R01 · FY2010 · AI · contact PI

Emerging drug-resistance infections$189,778

D43 · FY2010 · TW · contact PI

TRAINING IN INFECTIOUS DISEASES AND IMMUNITY RESEARCH (T32 AI007620)$124,806

T32 · FY2010 · AI · contact PI

In vivo regulation of M. tuberculosis cell wall lipids$361,812

R01 · FY2009 · AI · contact PI

Emerging drug-resistance infections$140,098

D43 · FY2009 · TW · contact PI

Orgin of multidrug resistant uropathogenic E. coli$282,770

R01 · FY2008 · AI · contact PI

Emerging drug-resistance infections$141,717

D43 · FY2008 · TW · contact PI

Orgin of multidrug resistant uropathogenic E. coli$288,247

R01 · FY2007 · AI · contact PI

Emerging drug-resistant infections$133,950

D43 · FY2007 · TW · contact PI

Orgin of multidrug resistant uropathogenic E. coli$296,856

R01 · FY2006 · AI · contact PI

Therapeutic vaccine against tuberculosis$259,750

R21 · FY2006 · AI · contact PI

Emerging drug-resistant infections$142,500

D43 · FY2006 · TW · contact PI

Orgin of multidrug resistant uropathogenic E. coli$297,760

R01 · FY2005 · AI

Therapeutic vaccine against tuberculosis$152,000

R21 · FY2005 · AI

Emerging drug-resistant infections$150,000

D43 · FY2005 · TW

Emerging drug-resistant infections$150,000

D43 · FY2004 · TW

Emerging drug-resistant infections$150,000

D43 · FY2003 · TW

Epidemiology of an uropathogenic E coli clonal group$75,750

R03 · FY2003 · AI

MOLECULAR BIOLOGY OF INFECTION WITH M TUBERCULOSIS$267,968

R01 · FY2002 · AI

LAB-BASED FIELD EPIDEMIOLOGY TRAINING IN EMERGING INFECT$259,490

D43 · FY2002 · TW

Epidemiology of an uropathogenic E coli clonal group$75,750

R03 · FY2002 · AI

LAB-BASED FIELD EPIDEMIOLOGY TRAINING IN EMERGING INFECT$508,903

D43 · FY2001 · TW

MOLECULAR BIOLOGY OF INFECTION WITH M TUBERCULOSIS$260,162

R01 · FY2001 · AI

ANTIOXIDANT GENES OF MYCOBACERIUM TUBERCULOSIS$238,142

R01 · FY2001 · HL

TB INTERNATIONAL TRAINING &RESEARCH PROGRAM$320,819

D43 · FY2000 · TW

MOLECULAR BIOLOGY OF INFECTION WITH M TUBERCULOSIS$252,586

R01 · FY2000 · AI

ANTIOXIDANT GENES OF MYCOBACERIUM TUBERCULOSIS$231,206

R01 · FY2000 · HL

LAB-BASED FIELD EPIDEMIOLOGY TRAINING IN EMERGING INFECT$193,168

D43 · FY2000 · TW